×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| SUN PHARMACEUTICAL INDUSTRIES | 1,41,410.80 | 29,129.80 | 1,36,754.60 | 12.10 | 3,94,391 | 33.4 |
| DIVIS LABORATORIES LTD. | 24010 | 5890 | 23190 | 22.20 | 152832 | 73.9 |
| CIPLA LTD. | 51595.7 | 14381.5 | 49708.8 | 17.79 | 119184 | 23.9 |
Sun Pharmaceutical Industries Ltd., with Security Code 524715, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,932.8 | 5,285.2 | 4,645.7 | 5,948.2 | 4,466.0 | 5,096.2 | 5,073.7 | 5,639.1 | 4,498.0 | 5,127.7 |
| Expenses | 3,483.2 | 3,622.1 | 3,646.4 | 3,587.6 | 3,517.3 | 3,709.9 | 3,714.8 | 3,745.6 | 3,737.0 | 3,789.1 |
| Operating Profit | 1,449.7 | 1,663.2 | 999.4 | 2,360.7 | 948.8 | 1,386.3 | 1,359.0 | 1,893.5 | 761.1 | 1,338.6 |
| OPM % | 29.39% | 31.47% | 21.51% | 39.69% | 21.24% | 27.2% | 26.78% | 33.58% | 16.92% | 26.11% |
| Other Income | 49.0 | 41.7 | 68.0 | -2,817.5 | 14.3 | 106.5 | 7.0 | 118.9 | 82.7 | 86.3 |
| Interest | 87.1 | 92.8 | 130.9 | 161.5 | 157.9 | 193.6 | 214.9 | 217.6 | 216.1 | 243.8 |
| Depreciation | 374.5 | 384.0 | 430.4 | 412.0 | 415.3 | 392.7 | 399.6 | 393.0 | 369.8 | 285.5 |
| Profit before tax | 1,037.1 | 1,228.2 | 506.1 | 1,907.5 | 539.1 | 906.5 | 821.3 | 1,401.8 | 257.9 | 895.6 |
| Tax % | 2.4% | 1.2% | 3.8% | -0.9% | 2.4% | 2% | 4% | 38.1% | 7.8% | 3.6% |
| Net Profit | 1,011.8 | 1,213.0 | 486.7 | -1,020.8 | 380.6 | 888.6 | 721.3 | 867.6 | 237.8 | 863.3 |
| EPS in Rs | 4.2 | 5.1 | 2 | -4.3 | 1.6 | 3.7 | 3 | 3.6 | 1 | 3.6 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10,952.3 | 11,241.0 | 10,930.7 | 11,940.8 | 12,192.4 | 12,380.7 | 11,982.9 | 12,652.8 | 13,291.4 | 13,675.5 |
| Expenses | 8,000.0 | 8,244.5 | 8,162.4 | 8,616.5 | 9,028.7 | 8,911.4 | 8,955.6 | 9,055.9 | 9,352.4 | 9,671.0 |
| Operating Profit | 2,952.3 | 2,996.4 | 2,768.3 | 3,324.4 | 3,163.7 | 3,469.3 | 3,027.3 | 3,596.9 | 3,939.0 | 4,004.5 |
| OPM % | 27% | 26.7% | 25.3% | 27.8% | 25.9% | 28% | 25.3% | 28.4% | 29.6% | 29.3% |
| Other Income | 85.2 | 173.9 | 201.8 | -118.4 | 293.6 | 180.4 | 504.3 | 532.6 | 354.0 | 149.5 |
| Interest | 19.4 | 46.2 | 92.7 | 80.9 | 49.3 | 34.7 | 73.6 | 61.5 | 69.2 | 51.5 |
| Depreciation | 610.0 | 660.0 | 671.5 | 651.3 | 632.8 | 622.1 | 650.4 | 655.1 | 625.9 | 630.6 |
| Profit before tax | 2,408.2 | 2,464.2 | 2,377.3 | 2,796.6 | 2,775.2 | 3,062.7 | 2,909.3 | 3,412.8 | 3,597.9 | 3,788.0 |
| Tax % | 6.3% | 11.5% | 10% | 18.9% | 14% | 14.4% | 5.3% | 16.1% | 15.8% | 16.1% |
| Net Profit | 2,255.9 | 2,180.8 | 1,982.9 | 2,005.7 | 2,385.1 | 2,560.5 | 2,658.7 | 2,860.5 | 3,037.3 | 2,913.0 |
| EPS in Rs | 9 | 9 | 8 | 8 | 9 | 10 | 11 | 11 | 12 | 12 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 15% |
| 3 Years: | 13% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 49% |
| 5 Years: | 10% |
| 3 Years: | 50% |
| TTM: | -24% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 33% |
| 3 Years: | 25% |
| 1 Year: | 5% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 11% |
| 3 Years: | 13% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 23% |
| 3 Years: | 25% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 33% |
| 3 Years: | 25% |
| 1 Year: | 5% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|